Incyte (INCY) EV to EBITDA (2010 - 2026)
Incyte's EV to EBITDA was 28.83 in Q3 2026, up 230.8% from 8.71 a year earlier and up 196.5% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) EV to EBITDA (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Incyte's EV to EBITDA was 12.10 through Sep 30, 2026, up 183.2% year-over-year; for FY2025, it was 9.96, down 86.6% from FY2024.
- In earlier years, EV to EBITDA was 74.38 in FY2024 (+401.6%), 14.83 in FY2023 (-34.5%), 22.64 in FY2022 (+5.0%) and 21.56 in FY2021.
- The Q3 2026 figure marks the highest quarterly EV to EBITDA since Q1 2025.
- Compared with a year earlier, EV to EBITDA was higher in four of the last eight quarters, with growth averaging 62.7%.
- The best year-over-year quarter for EV to EBITDA over five years was Q4 2024 (growth of 401.6%); the worst was Q3 2025 (a decline of 97.2%).
- Per Business Quant data, INCY's EV to EBITDA in the three quarters before Q3 2026 was 9.72 (Q2 2026), 8.68 (Q1 2026) and 9.96 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -4.98 |
| Jun 30, 2026 | -2.30 |
| Mar 31, 2026 | -2.24 |
| Dec 31, 2025 | -2.10 |
| Sep 30, 2025 | -1.76 |
| Jun 30, 2025 | -1.80 |
| Mar 31, 2025 | -8.67 |
| Dec 31, 2024 | -13.44 |
| Sep 30, 2024 | -46.44 |
| Jun 30, 2024 | -12.96 |
| Mar 31, 2024 | -4.82 |
| Dec 31, 2023 | -5.00 |
| Sep 30, 2023 | -5.81 |
| Jun 30, 2023 | -6.55 |
| Mar 31, 2023 | -5.29 |
| Dec 31, 2022 | -4.73 |
| Sep 30, 2022 | -4.13 |
| Jun 30, 2022 | -3.28 |
| Mar 31, 2022 | -3.57 |
| Dec 31, 2021 | -3.40 |
API Access
Incyte EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();